Generate a tailored SOP for Dr. Chiara Francavilla. Improve your application with a focused, well-structured draft.
Dr. Chiara Francavilla is an Honorary Senior Research Fellow at the University of Manchester, specializing in functional proteomics and endocytic trafficking of receptor tyrosine kinases (RTKs). She has been instrumental in advancing our understanding of intracellular signaling mechanisms, particularly the dynamics of RTK recycling in relation to cancer progression. Her research employs a multidisciplinary approach, integrating quantitative mass spectrometry, bioinformatics, and functional assays to characterize the roles of key signal transduction proteins. Dr. Francavilla has previously held prestigious research positions, including a Wellcome Trust Sir Henry Dale Fellowship and postdoctoral roles in leading molecular oncology centers in Europe. She is actively engaged in professional societies and committees, representing non-clinical fellows and contributing to various collaborative projects aimed at elucidating the molecular basis of receptor signaling pathways. Her PhD work laid the foundation for understanding the regulatory mechanisms of the Fibroblast Growth Factor Receptor (FGFR), a vital RTK in development and cancer. In addition, she has over several invited talks and conference presentations showcasing her research in the field.
Division of Cellular and Molecular Function, School of Biological Sciences, University of Manchester • Manchester, UK
Leading research on the mechanisms of endocytic trafficking and receptor signaling.
NNF-CPR (Novo Nordisk Foundation Center Protein Research), University of Copenhagen • Copenhagen, Denmark
Conducted research on protein interactions and cellular responses.
FIRC Institute of Molecular Oncology • Milan, Italy
Investigated molecular aspects of cancer development.
Includes MSc in Advanced Electrical Power Systems and MSc in Communications and Signal Processing.